Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Nitrous Oxide as Treatment for Fibromyalgia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating nitrous oxide as a treatment for fibromyalgia and central neuropathic pain, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: University of Chicago | Conditions: Fibromyalgia, Central Neuropathic Pain | Phase 2 | Status: RECRUITING